Short answer
Surgery Partners, Inc. (SGRY) filed its Q1 2026 10-Q quarterly report on May 5, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $811M (up 4.5% year over year) with net income of −$36M.
Q1 2026 key financials · XBRL
- Revenue
- $811M
- +4.5% YoY
- Net income
- −$36M
- +4.8% YoY
- Operating margin
- 8.1%
- EPS (diluted)
- −$0.28
- +6.7% YoY
Source: XBRL data from the Surgery Partners, Inc. (SGRY) Q1 2026 10-Q on SEC EDGAR. USD.
Surgery Partners, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q1 revenue $810.9M, up 4.5% YoY from $776.0M
- Operating margin 8.1% vs 8.0% YoY; net loss $35.9M vs $37.7M
- Same-facility revenue up 4.4%; revenue per case up 3.8%, cases up 0.6%
- Cash $182.3M vs $239.9M; operating cash flow $11.7M vs $6.0M
- Headwinds: interest rates, inflation, supply-chain risks and market volatility; liquidity adequate for 12 months and beyond
Risk Factors
- No material changes to risk factors from the 2025 Form 10-K
- No directors or officers adopted or terminated trading arrangements during the three months ended March 31, 2026
- New $200 million share repurchase authorization approved February 26, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Surgery Partners, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.